Letter in response to Othman & Favaloro "Comparison of two ways of performing ristocetin-induced platelet agglutination (RIPA) mixing study for diagnosis of type 2B VWD"

Res Pract Thromb Haemost. 2023 Aug 7;7(6):102165. doi: 10.1016/j.rpth.2023.102165. eCollection 2023 Aug.

Reza Soleimani^{1

2}, Mehdi Khourssaji^{1

2}, Julien Cabo^{1

2}, Maïté Guldenpfennig¹, Justine Baudar¹, Bernard Chatelain^{1

2}, Bérangère Devalet³, Marion Bareille^{1

2}, François Mullier^{1

2

4

5}

¹ Department of Laboratory Medicine, Hematology Laboratory, CHU UCL Namur, Yvoir, Belgium.
² Université Catholique De Louvain, Louvain-la-Neuve, Belgium.
³ Department of Hematology, Namur Research Institute for Life Sciences, Namur Thrombosis and Hemostasis Center, CHU UCL Namur, Université catholique de Louvain, Yvoir, Belgium.
⁴ Namur Thrombosis and Hemostasis Center, Namur, Belgium.
⁵ Institut de Recherche Expérimentale et Clinique (IREC), Pôle Mont, Université catholique de Louvain (UCLouvain), Yvoir, Belgium.

No abstract available